<qa>  What is the name of the treatment that patients from Belgian participating investigator sites were prescribed?Patients from Belgian participating investigator sites having been prescribed Depo-Eligard in accordance with the terms of the marketing authorization, on treatment with Depo-Eligard for at least six months. 